Home or hospital? An evaluation of the costs, preferences, and outcomes of domiciliary chemotherapy

M. T. King, J. Hall, S. Caleo, H. P. Gurney, P. R. Harnett

Research output: Contribution to journalArticleResearchpeer-review

Abstract

This study compares the costs and outcomes of domiciliary and hospital-based chemotherapy, using a prospective randomized cross-over design. Eighty-seven eligible patients were recruited from ontology services at two metropolitan hospitals in Sydney, Australia. Forty patients completed study evaluation requirements, having two months of chemotherapy in each location (home and hospital). The domiciliary service was staffed by hospital-based ontology nurses. Marginal costs of domiciliary treatment over hospital treatment were estimated from the health service perspective. Home-based care was more expensive, largely due to extra nurse time. About half of the eligible patients (n = 87) and 73 percent of the evaluated patients (n = 40) preferred domiciliary care. Most evaluated patients and their informal carers were satisfied with the medical care provided, regardless of location. Patient needs were well met in either location, and no differences were found in quality of life. At current throughput rates, providing chemotherapy in the home was more expensive than providing it in hospital. However, if the demand for chemotherapy were to exceed ward capacity by up to 50 percent, moving chemotherapy into the home could provide a less costly strategy for the expansion of a chemotherapy service without compromising patient outcomes.

LanguageEnglish
Pages557-579
Number of pages23
JournalInternational Journal of Health Services
Volume30
Issue number3
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Costs and Cost Analysis
Drug Therapy
Home Care Services
Nurses
Urban Hospitals
Health Care Costs
Cross-Over Studies
Caregivers
Health Services
Quality of Life
Therapeutics

Cite this

@article{bdd0e3321eb049449fc5ca05be70c3b9,
title = "Home or hospital? An evaluation of the costs, preferences, and outcomes of domiciliary chemotherapy",
abstract = "This study compares the costs and outcomes of domiciliary and hospital-based chemotherapy, using a prospective randomized cross-over design. Eighty-seven eligible patients were recruited from ontology services at two metropolitan hospitals in Sydney, Australia. Forty patients completed study evaluation requirements, having two months of chemotherapy in each location (home and hospital). The domiciliary service was staffed by hospital-based ontology nurses. Marginal costs of domiciliary treatment over hospital treatment were estimated from the health service perspective. Home-based care was more expensive, largely due to extra nurse time. About half of the eligible patients (n = 87) and 73 percent of the evaluated patients (n = 40) preferred domiciliary care. Most evaluated patients and their informal carers were satisfied with the medical care provided, regardless of location. Patient needs were well met in either location, and no differences were found in quality of life. At current throughput rates, providing chemotherapy in the home was more expensive than providing it in hospital. However, if the demand for chemotherapy were to exceed ward capacity by up to 50 percent, moving chemotherapy into the home could provide a less costly strategy for the expansion of a chemotherapy service without compromising patient outcomes.",
author = "King, {M. T.} and J. Hall and S. Caleo and Gurney, {H. P.} and Harnett, {P. R.}",
year = "2000",
language = "English",
volume = "30",
pages = "557--579",
journal = "International Journal of Health Services",
issn = "0020-7314",
publisher = "Baywood Publishing Co. Inc.",
number = "3",

}

Home or hospital? An evaluation of the costs, preferences, and outcomes of domiciliary chemotherapy. / King, M. T.; Hall, J.; Caleo, S.; Gurney, H. P.; Harnett, P. R.

In: International Journal of Health Services, Vol. 30, No. 3, 2000, p. 557-579.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Home or hospital? An evaluation of the costs, preferences, and outcomes of domiciliary chemotherapy

AU - King, M. T.

AU - Hall, J.

AU - Caleo, S.

AU - Gurney, H. P.

AU - Harnett, P. R.

PY - 2000

Y1 - 2000

N2 - This study compares the costs and outcomes of domiciliary and hospital-based chemotherapy, using a prospective randomized cross-over design. Eighty-seven eligible patients were recruited from ontology services at two metropolitan hospitals in Sydney, Australia. Forty patients completed study evaluation requirements, having two months of chemotherapy in each location (home and hospital). The domiciliary service was staffed by hospital-based ontology nurses. Marginal costs of domiciliary treatment over hospital treatment were estimated from the health service perspective. Home-based care was more expensive, largely due to extra nurse time. About half of the eligible patients (n = 87) and 73 percent of the evaluated patients (n = 40) preferred domiciliary care. Most evaluated patients and their informal carers were satisfied with the medical care provided, regardless of location. Patient needs were well met in either location, and no differences were found in quality of life. At current throughput rates, providing chemotherapy in the home was more expensive than providing it in hospital. However, if the demand for chemotherapy were to exceed ward capacity by up to 50 percent, moving chemotherapy into the home could provide a less costly strategy for the expansion of a chemotherapy service without compromising patient outcomes.

AB - This study compares the costs and outcomes of domiciliary and hospital-based chemotherapy, using a prospective randomized cross-over design. Eighty-seven eligible patients were recruited from ontology services at two metropolitan hospitals in Sydney, Australia. Forty patients completed study evaluation requirements, having two months of chemotherapy in each location (home and hospital). The domiciliary service was staffed by hospital-based ontology nurses. Marginal costs of domiciliary treatment over hospital treatment were estimated from the health service perspective. Home-based care was more expensive, largely due to extra nurse time. About half of the eligible patients (n = 87) and 73 percent of the evaluated patients (n = 40) preferred domiciliary care. Most evaluated patients and their informal carers were satisfied with the medical care provided, regardless of location. Patient needs were well met in either location, and no differences were found in quality of life. At current throughput rates, providing chemotherapy in the home was more expensive than providing it in hospital. However, if the demand for chemotherapy were to exceed ward capacity by up to 50 percent, moving chemotherapy into the home could provide a less costly strategy for the expansion of a chemotherapy service without compromising patient outcomes.

UR - http://www.scopus.com/inward/record.url?scp=0033779843&partnerID=8YFLogxK

M3 - Article

VL - 30

SP - 557

EP - 579

JO - International Journal of Health Services

T2 - International Journal of Health Services

JF - International Journal of Health Services

SN - 0020-7314

IS - 3

ER -